Unclaimed Scholar Profile
Are you Bernardo Leon Rapoport? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Bernardo Leon Rapoport
Faculty researcher at Milpark Hospital (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Cancer Immunotherapy and Biomarkers#Nausea and vomiting management#Breast Cancer Treatment Studies#Cancer Treatment and Pharmacology
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 11,543 | 5,541 |
| h-index | 47 | 35 |
| i10-index | 134 | 94 |
Annual Citation Growth
Verified Citations / Year0
2020554
2021+40%776
2022+28%997
2023+33%1.3k
2024-8%1.2k
2025-45%665
2026Scholarship Distribution & Proportions310 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (2,886) • 75% Global Research Impact (8,657)
310 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (310)
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients
Published in Journal of Clinical Oncology•2000
DOI: 10.1200/jco.2000.18.16.3038 Verified Peer-Reviewed
Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Published in Journal of Clinical Oncology•2001
DOI: 10.1200/jco.2001.19.11.2865 Verified Peer-Reviewed
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Published in Annals of Oncology•2016
DOI: 10.1093/annonc/mdw325 Verified Peer-Reviewed
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Published in Annals of Oncology•2010
DOI: 10.1093/annonc/mdq194 Verified Peer-Reviewed
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
Published in Annals of Oncology•2016
DOI: 10.1093/annonc/mdw270 Verified Peer-Reviewed
Showing 1 – 5 of 310 publications
1 / 62